Loading insider details...
Latest Form 4 (Nov 10, 2026): Sale of 11,866 VRTX shares, $6.31M.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Nov 10, 2026 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Sale | 11,866 | $6.31M |
| Mar 3, 2026 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Sale | 400 | $191.9K |
| Feb 26, 2026 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Tax Withholding | 4,981 | $2.42M |
| Feb 19, 2026 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Grant/Award | 16,326 | n/a |
| Feb 18, 2026 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Tax Withholding | 13,041 | $6.36M |
| Feb 12, 2026 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Tax Withholding | 8,297 | $3.89M |
| Jan 26, 2026 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Grant/Award | 26,972 | n/a |
| Aug 7, 2025 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Purchase | 4,290 | $1.67M |
| Feb 28, 2025 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Tax Withholding | 14,079 | $6.75M |
| Feb 26, 2025 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Tax Withholding | 9,386 | $4.54M |